Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
Andrea J ZimmerErica StohsJane MezaChristopher ArnoldJohn W BaddleyPranatharthi ChandrasekarZeinab El BoghdadlyCarlos A GomezEileen K MaziarzJose G MontoyaSteven PergamKenneth V RolstonMichael J SatlinGowri SatyanarayanaShmuel ShohamLynne StrasfeldRandy TaplitzThomas J WalshJo-Anne H YoungYuning ZhangAlison G FreifeldPublished in: Open forum infectious diseases (2022)
In accordance with US guidelines, cefepime or piperacillin-tazobactam remain effective agents or empirical treatment for high-risk cancer patients with FN who are stable at presentation, maintaining high GN pathogen susceptibility and yielding excellent outcomes.